Prevention of healthcare-associated Clostridium difficile infection: What works?

Infection Control and Hospital Epidemiology

Volumn 31, Issue SUPPL. 1, 2010, Pages

  Dubberke, Erik R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; CONFERENCE PAPER; DISEASE SEVERITY; ENDEMIC DISEASE; EPIDEMIC; HUMAN; INCIDENCE; INFECTION PREVENTION; NONHUMAN; TECHNIQUE;

CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INTENSIVE CARE UNITS;

EID: 78449259243     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/655985     Document Type: Conference Paper

References (25)

1. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(Suppl 1):S81-S92.
2. Yokoe DS, Classen D. Improving patient safety through infection control: a new healthcare imperative. Infect Control Hosp Epidemiol 2008;29(Suppl 1):S3-S11.
3. Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88(2):137-140. (Pubitemid 20051784)
4. Fowler S, Webber A, Cooper BS, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother 2007;59(5): 990-995. (Pubitemid 47073372)
5. Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994;120(4):272-277.
6. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45(Suppl 2):S112-S121. (Pubitemid 47328625)
7. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355(26):2725-2732. (Pubitemid 46021509)
8. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002;23(12):759-769. (Pubitemid 36020215)
9. Warren DK, Zack JE, Cox MJ, Cohen MM, Fraser VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med 2003;31(7): 1959-1963.
10. Warren DK, Cosgrove SE, Diekema DJ, et al. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 2006;27(7):662-669. (Pubitemid 44271945)
11. Abbett SK, Yokoe DS, Lipsitz SR, et al. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30(11): 1062-1069.
12. Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000;31(4): 995-1000.
13. Boyce JM, Ligi C, Kohan C, Dumigan D, Havill NL. Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 2006;27(5):479-483. (Pubitemid 43835530)
14. Department of Health and Human Services. HHS Action Plan to Prevent Healthcare-Associated Infections. http://www.hhs.gov/ophs/initiatives/ hai/actionplan/index.html. Accessed 31 August 2010.
15. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis 2009;15(5):819-821.
16. Hellickson LA, Owens KL. Cross-contamination of Clostridium difficile spores on bed linen during laundering. Am J Infect Control 2007;35(5): E32-E33.
17. Carbone HL, Hellickson LA, Thomasser AL, Vu LK. Clostrdium difficile cross contamination in the textile laundering process: the importance of selecting an appropriate hard surface disinfectant. In: Program and abstracts of the 5th Decennial International Conference on Healthcare- Associated Infections; March 18-22, 2010; Atlanta, GA. Abstract 160.
18. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166(3): 561-567.
19. Dubberke ER. The A, B, BI, and Cs of Clostridium difficile. Clin Infect Dis 2009;49(8):1148-1152.
20. Dubberke ER, Yan Y, Reske KA, Butler AM, Fraser VJ. Development of a Clostridium difficile-associated disease risk prediction model. In: Program and abstracts of the 18th Annual Meeting of the Society for Healthcare Epidemiology of America; April 5-8, 2008; Orlando, FL. Abstract 50.
21. Merrigan MM, Sambol SP, Johnson S, Gerding DN. New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration. Int J Antimicrob Agents 2009;33(Suppl 1):S46-S50.
22. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342(6):390-397. (Pubitemid 30084537)
23. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357(9251):189-193. (Pubitemid 32108091)
24. Lowy I, Molrine DC, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010;362(3):197-205.
25. Sougioultzis S, Kyne L, Drudy D, et al. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 2005;128(3): 764-770. (Pubitemid 40585378)